DK0750637T3 - CAI resistens, som koder for et protein, samt anvendelse deraf - Google Patents
CAI resistens, som koder for et protein, samt anvendelse derafInfo
- Publication number
- DK0750637T3 DK0750637T3 DK95914156T DK95914156T DK0750637T3 DK 0750637 T3 DK0750637 T3 DK 0750637T3 DK 95914156 T DK95914156 T DK 95914156T DK 95914156 T DK95914156 T DK 95914156T DK 0750637 T3 DK0750637 T3 DK 0750637T3
- Authority
- DK
- Denmark
- Prior art keywords
- cai
- protein
- resistance encoding
- functionally equivalent
- cai resistance
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- WNRZHQBJSXRYJK-UHFFFAOYSA-N carboxyamidotriazole Chemical compound NC1=C(C(=O)N)N=NN1CC(C=C1Cl)=CC(Cl)=C1C(=O)C1=CC=C(Cl)C=C1 WNRZHQBJSXRYJK-UHFFFAOYSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- XFVULMDJZXYMSG-ZIYNGMLESA-N 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid Chemical compound NC1=C(C(O)=O)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 XFVULMDJZXYMSG-ZIYNGMLESA-N 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 230000002596 correlated effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/212,190 US5652223A (en) | 1994-03-14 | 1994-03-14 | DNA encoding CAI resistance proteins and uses thereof |
| PCT/US1995/003610 WO1995025125A1 (en) | 1994-03-14 | 1995-03-14 | Dna encoding cai resistance proteins and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0750637T3 true DK0750637T3 (da) | 1999-08-30 |
Family
ID=22789940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95914156T DK0750637T3 (da) | 1994-03-14 | 1995-03-14 | CAI resistens, som koder for et protein, samt anvendelse deraf |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5652223A (da) |
| EP (1) | EP0750637B1 (da) |
| JP (1) | JPH09511236A (da) |
| AT (1) | ATE175212T1 (da) |
| AU (1) | AU684930B2 (da) |
| CA (1) | CA2185341A1 (da) |
| DE (1) | DE69507017T2 (da) |
| DK (1) | DK0750637T3 (da) |
| ES (1) | ES2128048T3 (da) |
| GR (1) | GR3029811T3 (da) |
| WO (1) | WO1995025125A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6790936B1 (en) | 1994-03-14 | 2004-09-14 | The United States Of America As Represented By The Department Of Health And Human Services | CAI resistance proteins and uses thereof |
| US5652223A (en) * | 1994-03-14 | 1997-07-29 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | DNA encoding CAI resistance proteins and uses thereof |
| US6696558B2 (en) * | 1998-09-09 | 2004-02-24 | The Burnham Institute | Bag proteins and nucleic acid molecules encoding them |
| EP1109824A4 (en) * | 1998-09-09 | 2002-06-05 | Burnham Inst | NEW 'BAG' PROTEINS AND THE NUCLEIC ACID MOLECULES CODING THEM |
| US7264810B2 (en) * | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
| EP1323733A1 (en) * | 2001-12-28 | 2003-07-02 | Arturo Leone | BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
| US7517697B2 (en) * | 2003-02-05 | 2009-04-14 | Applied Biosystems, Llc | Compositions and methods for preserving RNA in biological samples |
| US8551711B2 (en) | 2006-05-02 | 2013-10-08 | Teikyo University | Screening method of glutathione-increasing substance |
| EP2676966A1 (en) * | 2012-06-19 | 2013-12-25 | Biouniversa S.r.l. | BAG3 as biochemical serum and tissue marker |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5359078A (en) * | 1989-05-19 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Signal transduction inhibitor compounds |
| US5652223A (en) * | 1994-03-14 | 1997-07-29 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | DNA encoding CAI resistance proteins and uses thereof |
-
1994
- 1994-03-14 US US08/212,190 patent/US5652223A/en not_active Expired - Lifetime
-
1995
- 1995-03-14 CA CA002185341A patent/CA2185341A1/en not_active Abandoned
- 1995-03-14 AT AT95914156T patent/ATE175212T1/de not_active IP Right Cessation
- 1995-03-14 EP EP95914156A patent/EP0750637B1/en not_active Expired - Lifetime
- 1995-03-14 AU AU21263/95A patent/AU684930B2/en not_active Ceased
- 1995-03-14 DK DK95914156T patent/DK0750637T3/da active
- 1995-03-14 ES ES95914156T patent/ES2128048T3/es not_active Expired - Lifetime
- 1995-03-14 WO PCT/US1995/003610 patent/WO1995025125A1/en not_active Ceased
- 1995-03-14 DE DE69507017T patent/DE69507017T2/de not_active Expired - Fee Related
- 1995-03-14 JP JP7523722A patent/JPH09511236A/ja active Pending
-
1997
- 1997-07-25 US US08/900,321 patent/US5981712A/en not_active Expired - Lifetime
-
1999
- 1999-03-29 GR GR990400901T patent/GR3029811T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69507017D1 (de) | 1999-02-11 |
| AU2126395A (en) | 1995-10-03 |
| ES2128048T3 (es) | 1999-05-01 |
| US5981712A (en) | 1999-11-09 |
| CA2185341A1 (en) | 1995-09-21 |
| JPH09511236A (ja) | 1997-11-11 |
| EP0750637A1 (en) | 1997-01-02 |
| GR3029811T3 (en) | 1999-06-30 |
| DE69507017T2 (de) | 1999-08-12 |
| ATE175212T1 (de) | 1999-01-15 |
| EP0750637B1 (en) | 1998-12-30 |
| WO1995025125A1 (en) | 1995-09-21 |
| US5652223A (en) | 1997-07-29 |
| AU684930B2 (en) | 1998-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69939945D1 (de) | Verfahren zur isolierung von stammzellen | |
| WO2004033631A8 (en) | Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using | |
| NZ310657A (en) | Chimeric proteins for use in transport of a selected substance into cells | |
| ATE408422T1 (de) | Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten | |
| ATE310819T1 (de) | Säugetieren apoptosis inhibitorprotein genfamilie,primers, probes und verfahren zur nachweis | |
| CY2618B2 (da) | ||
| CO4870792A1 (es) | Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata | |
| PT765389E (pt) | Novos sistemas celulares tendo interaccao especifica de pares de peptidicos que se ligam mutuamente | |
| DE60140773D1 (de) | Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS) | |
| DK0510079T3 (da) | Proteiner, der er produceret af humane lymfocytter, DNA-sekvenser, der koder for disse proteiner, og farmaceutiske og biolo | |
| EP1499885A4 (en) | NOVEL FUSION PROTEINS AND ANALYSIS FOR THE DETECTION OF MOLECULAR BINDERS | |
| DE69434614D1 (de) | Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung | |
| AU5419399A (en) | Method for determining the immune defences of blood, test kit therefor and use of a suitable system for taking blood samples | |
| CA2192940A1 (en) | Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections | |
| BR9912455A (pt) | ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória | |
| DK0750637T3 (da) | CAI resistens, som koder for et protein, samt anvendelse deraf | |
| DE69201937D1 (de) | Biochemischer Sauerstoffbedarfanalysator, Verfahren zur Analyse, Mikroorganismen zur Verwendung in Analyse. | |
| ATE239274T1 (de) | Proteom-analyse zum charakterisieren von auf- und abgeregelten proteinen in biologischen proben | |
| EP1780537A4 (en) | PROTEOMANALYSIS PROCESS FOR PHOSPHORYLATED PROTEIN | |
| ATE316577T1 (de) | Das goodpasture-antigen bindende protein | |
| DK0643719T3 (da) | Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor | |
| MX9702863A (es) | Proteinas asociadas con el hipocampo, secuencias de adn que codifican para las mismas y usos de las mismas. | |
| PT1127133E (pt) | Polipeptido que proporciona permeabilidade celular | |
| AU4981093A (en) | Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof | |
| NZ332482A (en) | Human and clam cyclin-selective ubiquitin carrier polypeptides (E2) that are involved in the ubiquitination of cyclins A and B, inhibitors of these E2 polypeptides are included |